Late-onset systemic lupus erythematosus: A personal series of 47 patients and pooled analysis of 714 cases in the literature

Medicine

Volumn 83, Issue 6, 2004, Pages 348-359

  Boddaert, Jacques ^a   Huong, Du Le Thi ^a   Amoura, Zahir ^a   Wechsler, Bertrand ^a   Godeau, Pierre ^a   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; AGED; AGING; ALOPECIA; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; HAIR LOSS; HUMAN; INFLAMMATION; KIDNEY DISEASE; LABORATORY TEST; LUNG DISEASE; LYMPHADENOPATHY; MALE; MORTALITY; MYALGIA; NEPHRITIS; NEPHROTIC SYNDROME; NEUROPSYCHIATRY; PERICARDITIS; PHOTOSENSITIVITY; PLEURISY; POLYARTHRITIS; PRIORITY JOURNAL; PURPURA; RASH; RAYNAUD PHENOMENON; SEX DIFFERENCE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE OF ONSET; AGED; ANTIRHEUMATIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 9144271391     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000147737.57861.7c     Document Type: Article

References (66)

1. Abu-Shakra M, Ehrenfeld M, Shoenfeld Y. Systemic lupus erythematosus and cancer: associated or not? Lupus. 2002;11:137-144.
2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995;22:1259-1264.
3. Antolin J, Amerigo MJ, Cantabrana A, Roces A, Jimenez P. Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. Clin Rheumatol. 1995;14:678-685.
4. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2407-2415.
5. Baker SB, Rovira JR, Campion EW, Mills JA. Late onset systemic lupus erythematosus. Am J Med. 1979;66:727-732.
6. Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus. Differences related to race and age of onset. Arthritis Rheum. 1982;25:55-60.
7. Bynoe MS, Grimaldi CM, Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc Natl Acad Sci USA. 2000;97:2703-2708.
8. Catania A, Mangone I, Motta P, Zanussi C. Administration of gonadotropin-releasing hormone analog as adjunctive therapy in women with systemic lupus erythematosus. Arthritis Rheum. 1989;32:1186-1188.
9. Catoggio LJ, Skinner RP, Smith G, Maddison PJ. Systemic lupus erythematosus in the elderly: Clinical and serological characteristics. J Rheumatol. 1984;11:175-181.
10. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ingelmo M, Hughes GRV, and the European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993;72: 113-124.
11. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC. Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003;82:299-308.
12. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46:2924-2927.
13. Costallat LTL, Coimbra AMV. Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol. 1994;12:603-607.
14. Dimant J, Ginzler EM, Schlesinger M, Diamond HS, Kaplan D. Systemic lupus erythematosus in the older age group: Computer analysis. J Am Geriatr Soc. 1979;27:58-61.
15. Domenech I, Aydintug O, Cervera R, Khamashta M, Jedryka-Goral A, Vianna JL, Hughes GRV. Systemic lupus erythematosus in 50 year olds. Postgrad Med J. 1992;68:440-444.
16. Drenkard C, Villa AR, Alarcon-Segovia D, Perez-Vazquez ME. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol. 1994;21: 1067-1072.
17. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA. 1964;190: 104-111.
18. Foad BSI, Sheon RP, Kirsner AB. Systemic lupus erythematosus in the lderly. Arch Intern Med. 1972;130:743-746.
19. Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, Ingelmo M. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis. 1991;50:702-705.
20. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDA1. Lupus. 1999;8:462-465.
21. Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270-280.
22. Gaujard S, Broussolle C, Cathebras P, Dupond JL, Massot C, Ninet J, Perrot H, Vital Durand D, Rousset H. [Systemic lupus erythematosus with disease onset after age 65.] Rev Med Interne. 2003;24:288-294.
23. Gossat DM, Walls RS. Systemic lupus erythematosus in later life. Med J Aust. 1982;1:297-299.
24. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore). 1954;33:291-437.
25. Hashimoto H, Tsuda H, Hirano T, Takasaki Y, Matsumoto T, Hirose S. Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol. 1987;14:497-501.
26. Ho CTK, Mok CC, Lau CS, Wong RWS. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 1998;57:437-444.
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
28. Hochberg MC, Boyd RE, Ahearn JM, Arnert FC, Bias WB, Provost TT, Stevens MB. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore). 1985;64: 285-295.
29. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, van Overeem Hansen G, Skaarup B, Hansen TM, Podenphant J, Halberg P. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol. 1998;17:468-477.
30. Janwityanujit S, Totemchokchyakam K, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Age-related differences on clinical and immunological manifestations of SLE. Asian Pac J Allergy Immunol. 1995;13:145-149.
31. Jonsson H, Nived O, Sturfelt G. The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol. 1988;15:505-509.
32. Joseph RR, Zarafonetis CJD. Clinical onset of lupus erythematosus in the older age group. J Am Geriatr Soc. 1964;12:787-799.
33. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, Bach JF. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum. 1982;25:618-623.
34. Jungers P, Kuttenn F, Liote F, Pelissier C, Athea N, Laurent MC, Viriot J, Dougados M, Bach JF. Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. Arthritis Rheum. 1985;28:1243-1250.
35. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42:328-337.
36. Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol. 1994;21: 1463-1467.
37. Le Thi Huong D, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, Godeau P, Piette JC. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore). 1999;78:148-166.
38. Maddison P. Systemic lupus erythematosus in the elderly. J Rheumatol. 1987;14(Suppl 13):182-187.
39. Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol. 2002; 29:913-917.
40. Maddock RK. Incidence of systemic lupus erythematosus by age and sex. JAMA. 1965;191:137-138.
41. Mak SK, Lam EKM, Wong AKM. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus. 1998;7:23-28.
42. Manger K, Manger B, Repp R, Geisselbrecht M. Geiger A, Pfahlberg A, Harrer T. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002;61: 1065-1070.
43. Manoussis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM. Sjogren's syndrome associated with systemic lupus erythematosus. Clinical and laboratory profiles and comparison with primary Sjogren's syndrome. Arthritis Rheum. 2004;50:882-891.
44. McCombs RP, Patterson JF. Factors influencing the course and prognosis of systemic lupus erythematosus. N Engl J Med. 1959;260: 1196-1204.
45. Mok CC, Lau CS, Ho CT, Wong RW. Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol. 1999;28: 357-362.
46. Mok CC, Lau CS, Ho CTK, Lee KW, Mok MY, Wong RWS. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus. Scand J Rheumatol. 1998;27:342-346.
47. Mok CC, Lau CS, Wong RW. Use of exogenous estrogens in systemic lupus erythematosus. Semin Arthritis Rheum. 2001;30:426-435.
48. Mok CC, Wong RWS, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum. 1999;42:1274-1280.
49. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002;61: 409-413.
50. Pu SJ, Luo SF, Wu YJJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000; 9:96-100.
51. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990;33:37-48.
52. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399-2406.
53. Sanchez-Guerrero J, Liang HM, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk of developing systemic lupus erythematosus. Ann Intern Med. 1995;122:430-433.
54. Shaikh SK, Wang F. Late-onset systemic lupus erythematosus: clinical and immunological characteristics. Med J Malaysia. 1995;50: 25-31.
55. Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boegel WA, Smathers PA, Taurag JD, Weinlein L, Duvic M. Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum. 1979;22: 1170-1176.
56. Studenski S, Allen NB, Caldwell DS, Rice JR, Polisson RP. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum. 1987;30:1326-1332.
57. Takayasu V, Bonfa E, Levy Net M, Kumeda C, Daud R, Cossermelli W. Lupus eitematoso sistemico no idoso: caracteristicas clinicas e laboratoriais. Rev Hosp Clin Fac Med S Paulo. 1992;47:6-9.
58. Urowitz MB, Stevens MB, Shulman LE. The influence of age on the clinical pattern of systemic lupus erythematosus. Arthritis Rheum. 1967; 10:319.
59. van Vollenhoven RF, Park JL, Genovese MC, West JP, McGuire JL. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus. 1999;8: 181-187.
60. Ward MM, Polisson RP. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum. 1989;32: 1226-1232.
61. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum. 1995;38:1492-1499.
62. Ward MM, Studenski S. Systemic lupus erythematosus in men: a multivariate analysis of gender in clinical manifestations. J Rheumatol. 1990;17:220-224.
63. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42:338-346.
64. Wilson HA, Hamilton ME, Spyker DA, Brunner CM, O'Brien WM, Davis JS 4th, Winfield JB. Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum. 1981;24: 1230-1235.
65. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GRV, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum. 1999;42:1309-1311.
66. Zamber RW, Starkebaum G, Rubin RL, Martens HF, Wener MH. Drug induced systemic lupus erythematosus due to ophthalmic timolol. J Rheumatol. 1992;19:977-979.